ID

24254

Description

IMPROVE Study(The Individualized Management With PEGASYS and Ribavirin Offering Viral Eradication): A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Non-Genotype 2/3.; ODM derived from: https://clinicaltrials.gov/show/NCT00483938

Link

https://clinicaltrials.gov/show/NCT00483938

Keywords

  1. 7/28/17 7/28/17 -
Uploaded on

July 28, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hepatitis C, Chronic NCT00483938

Eligibility Hepatitis C, Chronic NCT00483938

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, >=18 years of age;
Description

Adult | Age

Data type

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
evidence of chc;
Description

Hepatitis C, Chronic

Data type

boolean

Alias
UMLS CUI [1]
C0524910
evidence of hepatitis c non-genotype 2 or 3;
Description

Hepatitis C virus genotype

Data type

boolean

Alias
UMLS CUI [1]
C1148363
compensated liver disease.
Description

Compensated liver disease

Data type

boolean

Alias
UMLS CUI [1]
C3839044
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
infection with hcv genotype 2 or 3;
Description

Hepatitis C virus genotype Infection

Data type

boolean

Alias
UMLS CUI [1,1]
C1148363
UMLS CUI [1,2]
C3714514
history of having received systemic antiviral therapy with activity against chc <=3 months prior to start of study;
Description

Antiviral Therapy Systemic | Activity Against Chronic Hepatitis C

Data type

boolean

Alias
UMLS CUI [1,1]
C0280274
UMLS CUI [1,2]
C0205373
UMLS CUI [2,1]
C0441655
UMLS CUI [2,2]
C0521124
UMLS CUI [2,3]
C0524910
hepatitis a, hepatitis b or hiv infection;
Description

Hepatitis A | Hepatitis B | HIV Infection

Data type

boolean

Alias
UMLS CUI [1]
C0019159
UMLS CUI [2]
C0019163
UMLS CUI [3]
C0019693
history or evidence of a medical condition associated with chronic liver disease other than chc.
Description

Medical condition Associated with Chronic liver disease | Chronic Hepatitis C Excluded

Data type

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0332281
UMLS CUI [1,3]
C0341439
UMLS CUI [2,1]
C0524910
UMLS CUI [2,2]
C2828389

Similar models

Eligibility Hepatitis C, Chronic NCT00483938

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, >=18 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Hepatitis C, Chronic
Item
evidence of chc;
boolean
C0524910 (UMLS CUI [1])
Hepatitis C virus genotype
Item
evidence of hepatitis c non-genotype 2 or 3;
boolean
C1148363 (UMLS CUI [1])
Compensated liver disease
Item
compensated liver disease.
boolean
C3839044 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Hepatitis C virus genotype Infection
Item
infection with hcv genotype 2 or 3;
boolean
C1148363 (UMLS CUI [1,1])
C3714514 (UMLS CUI [1,2])
Antiviral Therapy Systemic | Activity Against Chronic Hepatitis C
Item
history of having received systemic antiviral therapy with activity against chc <=3 months prior to start of study;
boolean
C0280274 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0441655 (UMLS CUI [2,1])
C0521124 (UMLS CUI [2,2])
C0524910 (UMLS CUI [2,3])
Hepatitis A | Hepatitis B | HIV Infection
Item
hepatitis a, hepatitis b or hiv infection;
boolean
C0019159 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019693 (UMLS CUI [3])
Medical condition Associated with Chronic liver disease | Chronic Hepatitis C Excluded
Item
history or evidence of a medical condition associated with chronic liver disease other than chc.
boolean
C3843040 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0341439 (UMLS CUI [1,3])
C0524910 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial